Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06138223` - The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)	N/A
Terminated	`NCT02906462` - Impact of an Early Palliative Approach	N/A
Terminated	`NCT02899585` - Expression of a Need of Implication for the Vulnerable Patient and His Adaptation	N/A

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT06138223 - The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)

N/A

Terminated

NCT02906462 - Impact of an Early Palliative Approach

N/A

Terminated

NCT02899585 - Expression of a Need of Implication for the Vulnerable Patient and His Adaptation

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04343365
Study type	Observational
Source	H. Lee Moffitt Cancer Center and Research Institute
Contact	Alaa Taha
Phone	813-745-7025
Email	Alaa.Taha@moffitt.org
Status	Recruiting
Phase
Start date	May 5, 2020
Completion date	March 2028

Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms